I am head of Medical Policy at GlaxoSmithKline (GSK) and chair our internal governance committee for clinical study disclosure. I have been involved in clinical study transparency for over 15 years which has included;
- The development of GSK’s policy on public disclosure of clinical research and launch of the GSK
clinical study register in 2005.
- Leading GSK's patient level data sharing initiative which launched in 2013
- Collaborating with other pharma companies on the development of a data sharing portal- Clinical
Study Data Request.com (https://www.clinicalstudydatarequest.com/)
- Published papers on data sharing including: Data Sharing as Part of the Normal Scientific
Process: A View from the Pharmaceutical Industry. Vallance P, Freeman A, Stewart M. PLoS Med. 2016 Jan 5;13(1) Data Sharing at a Crossroads. Rockhold F, Nisen P, Freeman A. N Engl J Med. 2016 Sep 22;375(12):1115-7.